Nov 10, 2022 07:00AM
Nov 10, 2022 07:00AM
Nov 9, 2022 08:00AM
Nov 9, 2022 08:00AM
Oct 24, 2022 08:02AM
Oct 24, 2022 08:00AM
Oct 24, 2022 08:00AM Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile Infection
Sep 1, 2022 08:03AM
Sep 1, 2022 08:00AM
Sep 1, 2022 08:00AM
Aug 25, 2022 04:31PM
Aug 25, 2022 04:30PM
Aug 25, 2022 04:30PM
Aug 11, 2022 07:00AM Finch Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
Aug 11, 2022 07:00AM
Aug 9, 2022 06:34AM
Jun 2, 2022 07:00AM
Jun 2, 2022 07:00AM
May 17, 2022 09:03AM
May 17, 2022 08:00AM
May 17, 2022 08:00AM Finch Therapeutics to Present at the H.C. Wainwright Global Investment Conference
May 16, 2022 07:00AM
May 16, 2022 07:00AM
May 9, 2022 08:22AM
May 9, 2022 08:22AM
Apr 29, 2022 09:02AM
Apr 29, 2022 08:51AM
Apr 28, 2022 05:24PM Finch Therapeutics (FNCH) Announces Removal of FDA Clinical Hold on CP101 IND
Apr 28, 2022 05:20PM
Apr 28, 2022 05:20PM
Apr 19, 2022 08:32AM
Apr 19, 2022 08:30AM
Apr 19, 2022 08:30AM
Apr 4, 2022 08:15AM
Mar 31, 2022 04:56PM Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Mar 31, 2022 04:56PM
Mar 1, 2022 04:32PM
Mar 1, 2022 04:30PM
Mar 1, 2022 04:30PM
Feb 23, 2022 07:00AM
Feb 23, 2022 07:00AM
Feb 10, 2022 07:00AM Finch Therapeutics Announces Additions to Senior Leadership Team
Feb 10, 2022 07:00AM
Jan 6, 2022 07:00AM
Jan 6, 2022 07:00AM
Jan 4, 2022 07:00AM
Jan 4, 2022 07:00AM
Dec 20, 2021 07:00AM
Dec 20, 2021 07:00AM Finch Therapeutics Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer
Nov 11, 2021 07:00AM

322,095 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All